Liposome-Encapsulated Botulinum Toxin A in Treatment of Functional Bladder Disorders

Botulinum toxin A (BoNT-A) intravesical injections have been used to treat patients with refractory functional bladder disorders such as overactive bladder (OAB) and interstitial cystitis/bladder pain syndrome (IC/BPS), but the risk of adverse events and the need for repeated injections continue to...

Descripción completa

Detalles Bibliográficos
Autores principales: Hung, Fan-Ching, Kuo, Hann-Chorng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781836/
https://www.ncbi.nlm.nih.gov/pubmed/36548734
http://dx.doi.org/10.3390/toxins14120838

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9781836/
https://www.ncbi.nlm.nih.gov/pubmed/36548734
http://dx.doi.org/10.3390/toxins14120838

Ejemplares similares